Clinical Trial Update: Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating atomoxetine for improving psychosocial functioning in children and adolescents with ADHD has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Atomoxetine (Strattera) (Atomoxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 3 | Status: COMPLETED | Results posted: 2010-01-06